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Background:  The soluble receptor for advanced glycation end products (sRAGE) participates in the pathogenesis of vascular disease, while 
subclinical inflammatory processes and increased asymmetric dimethylarginine (ADMA) levels are related to atherosclerosis progression. In this 
study we sought to determine the relationships of sRAGE with ADMA and high-sensitivity C-reactive protein (hs-CRP) levels in hypertension.
Methods:  Our population consisted of 320 newly diagnosed untreated non-diabetic patients with stage I to II essential hypertension [192 men, 
mean age=52 years, office blood pressure (BP)=145/93 mmHg]. In all participants, venous blood sampling was performed to estimate metabolic 
profile, hs-CRP and sRAGE levels. The distribution of sRAGE was split by the median (1060.1 pg/ml) and accordingly subjects were stratified into 
those with high and low values.
Results:  Patients with low sRAGE (n=164) compared to those with high sRAGE values (n=156) had greater body mass index (29.7±4.5 vs 
27.1±2.5 kg/m2, p<0.05) and 24-h systolic BP (139±8 vs 131±6 mmHg, p=0.001), while did not differ regarding metabolic profile (p=NS for all). 
Moreover, patients with low sRAGE compared to those with high sRAGE levels exhibited higher hs-CRP (5.2±2.4 vs 2.1±1.5 mg/l, p<0.0001) and 
ADMA (0.59±0.06 vs 0.51±0.05 μmol/l, p<0.0001), independently of confounders. In the total population, sRAGE was associated with body mass 
index (r=-0.245, p=0.006), 24-h pulse pressure (r=-0.3721, p=0.001), hs-CRP (r=-0.294, p=0.004) and ADMA (r=-0.366, p=0.004). Regarding 
ADMA, it was related to waist to hip ratio (r=0.324, p=0.004) and 24-h systolic BP (r=0.491, p<0.0001). Multiple regression analysis revealed that 
body mass index, 24-h systolic BP, hs-CRP and ADMA were the independent predictors of sRAGE (R2=0.49, p<0.0001).
Conclusion: In essential hypertension, decreased sRAGE levels are associated with pronounced inflammatory activation and endothelial 
dysfunction, as reflected by increased hs-CRP and ADMA levels. Moreover, the close relation of sRAGE with hs-CRP and ADMA, underscores the 
emerging role of this receptor in the progression of vascular atherosclerosis in the hypertensive setting.
